| Literature DB >> 33373380 |
Richard Muwonge1, Partha Basu1, Tarik Gheit2, Devasena Anantharaman3, Yogesh Verma4, Neerja Bhatla5, Smita Joshi6, Pulikottil O Esmy7, Usha Rani Reddy Poli8, Anand Shah9, Eric Zomawia10, Surendra S Shastri11, Sharmila Pimple12, Priya R Prabhu3, Sanjay Hingmire13, Aruna Chiwate13, Catherine Sauvaget1, Eric Lucas1, Sylla G Malvi13, Maqsood Siddiqi14, Subha Sankaran3, Thiraviam Pillai Rameshwari Ammal Kannan3, Rintu Varghese3, Uma Divate6, Shachi Vashist5, Gauravi Mishra12, Radhika Jadhav6, Massimo Tommasino2, M Radhakrishna Pillai3, Rengaswamy Sankaranarayanan15, Kasturi Jayant15.
Abstract
In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated women and followed up yearly. We assess type-specific prevalence, natural history and potential determinants of human papillomavirus (HPV) infection in these unvaccinated women. Cervical samples were collected yearly for at least four consecutive years. A Multiplex Type-Specific E7-Based polymerase chain reaction assay was used to detect 21 HPV types. HPV prevalence was 36.4% during 6 years. Most common HPV types were 16 (6.5%) and 31 (6.1%). Highest persistence were observed for HPV 35 (62.5%) and 52 (25%). New HPV acquisition rate was 5.6/1000 person-months of observation (PMO), highest for HPV 16 (1.1/1000 PMO). Type-specific clearance rates ranged between 2.9-5.5/100 PMO. HPV 16 and/or 18 infections were 41% (95% CI 4-63%) lower among women with 2-<3 years between marriage and first cervical sample collection compared to those with <2 years. HPV prevalence and acquisition rates in young Indian women were lower than their Western counterparts. HPV 16 infections being most common shows the importance and potential impact of HPV vaccination in India. Women with 2-3 years exposure had reduced risk possibly due to higher infections clearance.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33373380 PMCID: PMC7771682 DOI: 10.1371/journal.pone.0244242
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240